People · Operator
Named in public records as an officer, director or promoter · active 2019–2022 · Other Health Care, Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Code Biotherapeutics, Inc. | — | Other Health Care | Series B | $47.5M | $465.8M | 2022 |
| PassPort Technologies, Inc. | — | Pharmaceuticals | Series B | $30.0M | $1.0B | 2019 |
Victor Stone at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Victor Stone on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Edward Mathers | 1 | 12 |
| Russ Fein | 1 | 4 |
| Dmitry Kuzmin | 1 | 3 |
| Robert Lin | 1 | 2 |
| Joseph Truitt | 1 | 2 |
| Erin C Brubaker | 1 | 1 |
| Dmitry C. Kuzmin | 1 | 1 |
| Victor C. Stone | 1 | 1 |
| Edward C. Mathers | 1 | 1 |
| Robert C. Lin | 1 | 1 |
| Yuki Hasegawa | 1 | 1 |
| Tomoyuki Fujisawa | 1 | 1 |
| Brian McVeigh | 1 | 1 |
| Kathy Rouan | 1 | 1 |
| Robert C Getts | 1 | 1 |
| Lauren C Kaskiel | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.